HapticV1, PubMed, Corpus, bibRecord, 001781

Iridocyclitis associated with angle-supported phakic intraocular lenses.

Identifieur interne : 001781 ( PubMed/Corpus ); précédent : 001780; suivant : 001782

Iridocyclitis associated with angle-supported phakic intraocular lenses.

Auteurs : Antonio Leccisotti

Source :

Journal of cataract and refractive surgery [ 0886-3350 ] ; 2006.

RBID : pubmed:16814060

English descriptors

KwdEn :
- Adult, Anterior Chamber (surgery), Anti-Bacterial Agents (therapeutic use), Drug Therapy, Combination, Female, Glucocorticoids (therapeutic use), Humans, Hyperopia (surgery), Incidence, Iridocyclitis (diagnosis), Iridocyclitis (drug therapy), Iridocyclitis (etiology), Lens Implantation, Intraocular (methods), Lens, Crystalline (physiology), Lenses, Intraocular (adverse effects), Male, Middle Aged, Myopia (surgery), Odds Ratio, Prognosis, Retrospective Studies, Risk Factors, Visual Acuity.
MESH :
- chemical , therapeutic use : Anti-Bacterial Agents, Glucocorticoids.
- adverse effects : Lenses, Intraocular.
- diagnosis : Iridocyclitis.
- drug therapy : Iridocyclitis.
- etiology : Iridocyclitis.
- methods : Lens Implantation, Intraocular.
- physiology : Lens, Crystalline.
- surgery : Anterior Chamber, Hyperopia, Myopia.
- Adult, Drug Therapy, Combination, Female, Humans, Incidence, Male, Middle Aged, Odds Ratio, Prognosis, Retrospective Studies, Risk Factors, Visual Acuity.

Abstract

To evaluate incidence, features, risk factors, and prognosis of iridocyclitis after angle-supported phakic intraocular lens (IOL) implantation.

DOI: 10.1016/j.jcrs.2006.02.030
PubMed: 16814060

Links to Exploration step

pubmed:16814060

Le document en format XML

<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Iridocyclitis associated with angle-supported phakic intraocular lenses.</title>
<author><name sortKey="Leccisotti, Antonio" sort="Leccisotti, Antonio" uniqKey="Leccisotti A" first="Antonio" last="Leccisotti">Antonio Leccisotti</name>
<affiliation><nlm:affiliation>Ophthalmic Surgery Unit, Casa di Cura Rugani, Siena, Italy. leccisotti@libero.it</nlm:affiliation>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2006">2006</date>
<idno type="doi">10.1016/j.jcrs.2006.02.030</idno>
<idno type="RBID">pubmed:16814060</idno>
<idno type="pmid">16814060</idno>
<idno type="wicri:Area/PubMed/Corpus">001781</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">Iridocyclitis associated with angle-supported phakic intraocular lenses.</title>
<author><name sortKey="Leccisotti, Antonio" sort="Leccisotti, Antonio" uniqKey="Leccisotti A" first="Antonio" last="Leccisotti">Antonio Leccisotti</name>
<affiliation><nlm:affiliation>Ophthalmic Surgery Unit, Casa di Cura Rugani, Siena, Italy. leccisotti@libero.it</nlm:affiliation>
</affiliation>
</author>
</analytic>
<series><title level="j">Journal of cataract and refractive surgery</title>
<idno type="ISSN">0886-3350</idno>
<imprint><date when="2006" type="published">2006</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Adult</term>
<term>Anterior Chamber (surgery)</term>
<term>Anti-Bacterial Agents (therapeutic use)</term>
<term>Drug Therapy, Combination</term>
<term>Female</term>
<term>Glucocorticoids (therapeutic use)</term>
<term>Humans</term>
<term>Hyperopia (surgery)</term>
<term>Incidence</term>
<term>Iridocyclitis (diagnosis)</term>
<term>Iridocyclitis (drug therapy)</term>
<term>Iridocyclitis (etiology)</term>
<term>Lens Implantation, Intraocular (methods)</term>
<term>Lens, Crystalline (physiology)</term>
<term>Lenses, Intraocular (adverse effects)</term>
<term>Male</term>
<term>Middle Aged</term>
<term>Myopia (surgery)</term>
<term>Odds Ratio</term>
<term>Prognosis</term>
<term>Retrospective Studies</term>
<term>Risk Factors</term>
<term>Visual Acuity</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en"><term>Anti-Bacterial Agents</term>
<term>Glucocorticoids</term>
</keywords>
<keywords scheme="MESH" qualifier="adverse effects" xml:lang="en"><term>Lenses, Intraocular</term>
</keywords>
<keywords scheme="MESH" qualifier="diagnosis" xml:lang="en"><term>Iridocyclitis</term>
</keywords>
<keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>Iridocyclitis</term>
</keywords>
<keywords scheme="MESH" qualifier="etiology" xml:lang="en"><term>Iridocyclitis</term>
</keywords>
<keywords scheme="MESH" qualifier="methods" xml:lang="en"><term>Lens Implantation, Intraocular</term>
</keywords>
<keywords scheme="MESH" qualifier="physiology" xml:lang="en"><term>Lens, Crystalline</term>
</keywords>
<keywords scheme="MESH" qualifier="surgery" xml:lang="en"><term>Anterior Chamber</term>
<term>Hyperopia</term>
<term>Myopia</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Adult</term>
<term>Drug Therapy, Combination</term>
<term>Female</term>
<term>Humans</term>
<term>Incidence</term>
<term>Male</term>
<term>Middle Aged</term>
<term>Odds Ratio</term>
<term>Prognosis</term>
<term>Retrospective Studies</term>
<term>Risk Factors</term>
<term>Visual Acuity</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">To evaluate incidence, features, risk factors, and prognosis of iridocyclitis after angle-supported phakic intraocular lens (IOL) implantation.</div>
</front>
</TEI>
<pubmed><MedlineCitation Owner="NLM" Status="MEDLINE"><PMID Version="1">16814060</PMID>
<DateCreated><Year>2006</Year>
<Month>07</Month>
<Day>03</Day>
</DateCreated>
<DateCompleted><Year>2006</Year>
<Month>08</Month>
<Day>31</Day>
</DateCompleted>
<Article PubModel="Print"><Journal><ISSN IssnType="Print">0886-3350</ISSN>
<JournalIssue CitedMedium="Print"><Volume>32</Volume>
<Issue>6</Issue>
<PubDate><Year>2006</Year>
<Month>Jun</Month>
</PubDate>
</JournalIssue>
<Title>Journal of cataract and refractive surgery</Title>
<ISOAbbreviation>J Cataract Refract Surg</ISOAbbreviation>
</Journal>
<ArticleTitle>Iridocyclitis associated with angle-supported phakic intraocular lenses.</ArticleTitle>
<Pagination><MedlinePgn>1007-10</MedlinePgn>
</Pagination>
<Abstract><AbstractText Label="PURPOSE" NlmCategory="OBJECTIVE">To evaluate incidence, features, risk factors, and prognosis of iridocyclitis after angle-supported phakic intraocular lens (IOL) implantation.</AbstractText>
<AbstractText Label="SETTING" NlmCategory="METHODS">Private practice, Siena, Italy.</AbstractText>
<AbstractText Label="METHODS" NlmCategory="METHODS">This retrospective analysis comprised 356 consecutive eyes of 212 patients. In myopic eyes, the ZSAL-4 IOL (205 eyes of 125 patients) or the ZSAL-4 Plus IOL (106 eyes of 63 patients) was used. In hyperopic eyes (45 eyes of 24 patients), the Type 54 IOL was implanted. Haptic posterior angulation was 19 degrees (ZSAL-4), 23 degrees (ZSAL-4 Plus), and 14 degrees (Type 54).</AbstractText>
<AbstractText Label="RESULTS" NlmCategory="RESULTS">Clinically significant iridocyclitis occurred in 11 eyes (3.1%) of 11 patients. Mean patient age was 37.3 years +/- 9.4 (SD). Sixty-four percent were male (odds ratio [OR], 3.0; 95% confidence interval [CI], 0.8 to 7.4, not statistically significant). Iridocyclitis was observed in 4.4% of hyperopic eyes (OR, 1.6; 95% CI, 0.3 to 7.4; not statistically significant) and in 2.9% of myopic eyes. In myopic eyes, it followed the implantation of ZSAL-4 IOL in 3.9% of eyes (OR, 4.1; 95% CI, 0.5 to 33.6; not statistically significant), and of ZSAL-4 Plus IOL in 1%. Mean time from surgery was 8.5 +/- 10.6 months). Presentation included aqueous flare (100%), posterior synechiae (82%), blurred vision (82%), redness (36%), pain (27%), IOL precipitates (18%), and angular synechiae (9%). Only 1 patient had recurrences, leading to IOL explantation and cataract surgery. After topical therapy, best spectacle-corrected visual acuity was fully recovered in 9 of 11 eyes.</AbstractText>
<AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Iridocyclitis can occur months or years after the implantation of angle-supported phakic IOLs. No statistically significant risk factors were identified. Functional prognosis is generally good.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Leccisotti</LastName>
<ForeName>Antonio</ForeName>
<Initials>A</Initials>
<AffiliationInfo><Affiliation>Ophthalmic Surgery Unit, Casa di Cura Rugani, Siena, Italy. leccisotti@libero.it</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo><Country>United States</Country>
<MedlineTA>J Cataract Refract Surg</MedlineTA>
<NlmUniqueID>8604171</NlmUniqueID>
<ISSNLinking>0886-3350</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList><Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D000900">Anti-Bacterial Agents</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D005938">Glucocorticoids</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList><MeshHeading><DescriptorName MajorTopicYN="N" UI="D000328">Adult</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D000867">Anterior Chamber</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000601">surgery</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D000900">Anti-Bacterial Agents</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000627">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D004359">Drug Therapy, Combination</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D005260">Female</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D005938">Glucocorticoids</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000627">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D006956">Hyperopia</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000601">surgery</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D015994">Incidence</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D015863">Iridocyclitis</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000175">diagnosis</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000188">drug therapy</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000209">etiology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D019654">Lens Implantation, Intraocular</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000379">methods</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D007908">Lens, Crystalline</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000502">physiology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D007910">Lenses, Intraocular</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000009">adverse effects</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D008297">Male</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D008875">Middle Aged</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D009216">Myopia</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000601">surgery</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D016017">Odds Ratio</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D011379">Prognosis</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D012189">Retrospective Studies</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D012307">Risk Factors</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D014792">Visual Acuity</DescriptorName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<PubmedData><History><PubMedPubDate PubStatus="received"><Year>2005</Year>
<Month>9</Month>
<Day>12</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="accepted"><Year>2005</Year>
<Month>9</Month>
<Day>12</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed"><Year>2006</Year>
<Month>7</Month>
<Day>4</Day>
<Hour>9</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline"><Year>2006</Year>
<Month>9</Month>
<Day>1</Day>
<Hour>9</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez"><Year>2006</Year>
<Month>7</Month>
<Day>4</Day>
<Hour>9</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList><ArticleId IdType="pii">S0886-3350(06)00219-7</ArticleId>
<ArticleId IdType="doi">10.1016/j.jcrs.2006.02.030</ArticleId>
<ArticleId IdType="pubmed">16814060</ArticleId>
</ArticleIdList>
</PubmedData>
</pubmed>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Ticri/CIDE/explor/HapticV1/Data/PubMed/Corpus

HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001781 | SxmlIndent | more

HfdSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd -nk 001781 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Ticri/CIDE
   |area=    HapticV1
   |flux=    PubMed
   |étape=   Corpus
   |type=    RBID
   |clé=     pubmed:16814060
   |texte=   Iridocyclitis associated with angle-supported phakic intraocular lenses.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/RBID.i   -Sk "pubmed:16814060" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd   \
       | NlmPubMed2Wicri -a HapticV1

This area was generated with Dilib version V0.6.23.
Data generation: Mon Jun 13 01:09:46 2016. Site generation: Wed Mar 6 09:54:07 2024

	Serveur d'exploration sur les dispositifs haptiques
	Attention, ce site est en cours de développement ! Attention, site généré par des moyens informatiques à partir de corpus bruts. Les informations ne sont donc pas validées.

Serveur d'exploration sur les dispositifs haptiques

Iridocyclitis associated with angle-supported phakic intraocular lenses.

Iridocyclitis associated with angle-supported phakic intraocular lenses.

Source :

English descriptors

Abstract

Links to Exploration step

Le document en format XML

Pour manipuler ce document sous Unix (Dilib)

Pour mettre un lien sur cette page dans le réseau Wicri

Pour générer des pages wiki